ProteinLogic, the biomarker discovery and exploitation company, has appointed Mr Mahesh Shah (MBA) as Executive Chairman to lead the business as it expands into the TB diagnostics space.
Mahesh Shah was the founder and CEO of the retail pharmacy business Nucare PLC, a company with operations in the UK as well as overseas. Under his stewardship the business grew both organically and through joint ventures and acquisitions, and he led a successful trade sale in 2007, realising an enterprise value of approximately £70 million.

Mr Shah has professional qualifications in pharmacy, accounting, finance and business, and has extensive practical expertise in international business. He has held board positions with a number of start-up companies, playing a significant role in strategy and commercial agreements.

He has been involved with ProteinLogic for over 5 years, in executive and non-executive roles, and in this time, amongst other achievements, he has successfully raised over £5m in funding and forged productive collaborations with academics, research scientists, clinicians and third party suppliers and contractors.

Mr Shah’s commercial expertise and professional knowledge of the healthcare sector will be a particular asset when it comes to developing ProteinLogic’s commercial offering. On agreeing his appointment, Mr Shah commented: “Having been a part of the PL family for some years, I am enthusiastic about the company’s potential and I look forward to augmenting its growth and steering it through any future challenges. I am delighted to have a talented and committed team around me as we pursue our commercial and technical ambitions.”